The classifications for the 355 prostate cancer patients’ expression of UBE2O were as follows: grade 0 (n = 0), grade 1 (n = 120), grade 2 (n = 154), and grade 3 (n = 81). The gene discussed is UBE2O; the disease is prostate carcinoma.